Skip to content
OpenCapital
Get started

TELA Bio TELA Q4 2025 Annual earnings

Reported March 24, 2026 · After market close

Revenue$20.9MMiss by $165.2K
EPS-$0.16Beat by $0.02
Revenue estimate$21.0M
EPS estimate-$0.18

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$20.0M
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$19.1MBeat by $462.3K
Q4 2025$20.9MMiss by $165.2K
Q3 2025$20.7MMiss by $352.4KQ2 2025$20.2MMiss by $1.9MQ1 2025$18.5MBeat by $1.2MQ4 2024$17.6MMiss by $3.4M

Diluted EPS

Q1 2026-$0.21Miss by $0.07
Q4 2025-$0.16Beat by $0.02
Q3 2025-$0.19Miss by $0.02Q2 2025-$0.22Miss by $0.04Q1 2025-$0.25Miss by $0.04Q4 2024-$0.23Beat by $0.01

Ask the moment TELA Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did TELA Bio report Q4 2025 earnings?
TELA Bio (TELA) reported Q4 2025 earnings on March 24, 2026 after market close.
What were TELA Bio's Q4 2025 revenue and EPS?
TELA Bio reported revenue of $20.9M and eps of $-0.16 for Q4 2025.
Did TELA Bio beat estimates in Q4 2025?
Revenue missed the consensus estimate of $21.0M by $165.2K. EPS beat the consensus estimate of $-0.18 by $0.02.
How did TELA Bio's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.2% from $17.6M a year earlier and eps grew 30.4% from $-0.23.
Where can I find TELA Bio's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-033839) and the 10-K periodic report (0001104659-26-034507) directly on SEC EDGAR. The filing index links above go to sec.gov.